ANIP
ANI Pharmaceuticals, Inc.81.10
-0.41-0.5%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
1.82BP/E (TTM)
50.69Basic EPS (TTM)
1.60Dividend Yield
0%Recent Filings
8-K
8-K
10-Q
8-K
Preferred stock fully converted
ANI Pharmaceuticals fully converted its outstanding Series A Convertible Preferred Stock into common shares on September 26, 2025, eliminating all preferred obligations. Ampersand, the holder, first converted 5,000 shares into 120,580 common shares on August 14, 2025, at $41.4662 per share; the remaining 20,000 shares became 482,320 common shares after meeting the mandatory trigger of the stock's volume-weighted average price exceeding 170% of the conversion price over 20 of 30 trading days. This simplifies the capital structure, ending 6.50% cumulative dividends tied to the original $25 million investment from the 2021 Novitium Pharma acquisition. No preferred shares remain.
8-K
ANI unveils strong Q2 results
ANI Pharmaceuticals' CEO Nikhil Lalwani presents at the H.C. Wainwright Global Investment Conference on September 8, 2025, and Morgan Stanley Global Healthcare Conference on September 9, unveiling an updated investor deck. It spotlights robust Q2 2025 results, with total revenues hitting $211M—up 53% year-over-year—fueled by Cortrophin Gel's $82M surge and 98% Rare Disease growth. Guidance holds steady: $818-843M net revenue and $213-223M adjusted non-GAAP EBITDA for 2025. Supply chain risks linger from single-source manufacturing.
IPO
Employees
Sector
Industry
AMPH
Amphastar Pharmaceuticals, Inc.
25.61-0.70
AMRX
Amneal Pharmaceuticals, Inc.
12.17-0.29
ANIK
Anika Therapeutics Inc.
9.51-0.06
AYTU
Aytu BioPharma, Inc.
2.42+0.09
BIOE
Bio Essence Corp.
0.05+0.00
CPHI
China Pharma Holdings, Inc.
1.44-0.09
ELTP
Elite Pharmaceuticals, Inc.
0.50+0.00
NIKA
NIKA PHARMACEUTICALS INC.
0.28+0.00
NXEN
Nexien BioPharma, Inc.
0.00+0.00
UPC
Universe Pharmaceuticals Inc
3.68+0.05